Celltrion reported KRW399.04B in Cost of Sales for its fiscal quarter ending in March of 2025.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
Avita Medical AUD 2.28M 170K Dec/2024
Celltrion KRW 399.04B 120.81B Mar/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Moderna USD 119M 29M Jun/2025
Organon & Co USD 720M 48M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025